Source: India.com

New Delhi: Two days after the World Health Organisation (WHO) put a pause on clinical trials of hydroxychloroquine (HCQ) for COVID-19, the Council of Scientific and Industrial Research (CSIR) said that India will continue the use of the anti-malarial drug.

“I’m sure WHO will take considered call in coming time. We should trust ICMR’s judgement, they are well qualified. Hence, we should continue.”

CSIR DG Shekhar Mande

Read the original article here: https://www.india.com/news/india/india-should-continue-use-of-hydroxychloroquine

Nigeria: NAFDAC To Continue Hydroxychloroquine Trial Despite WHO’s Directive

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories